Signe And NotB. Ballanger
List of bibliographic references
Number of relevant bibliographic references: 9.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000170 | W. G. Meissner [France] | When does Parkinson's disease begin? From prodromal disease to motor signs |
| 000210 | Bénédicte Ballanger [France] ; Alice Poisson [France] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France] | Functional imaging of non-motor signs in Parkinson's disease |
| 000220 | Asha Kishore [Inde] ; Thomas Joseph [Inde] ; Balu Velayudhan [Inde] ; Traian Popa [France] ; Sabine Meunier [France] | Early, severe and bilateral loss of LTP and LTD-like plasticity in motor cortex (M1) in de novo Parkinson's disease |
| 000385 | P. Derkinderen [France] | Quelles pistes pharmacologiques non-dopaminergiques pour le traitement de la maladie de Parkinson ? |
| 000618 | Florence Portet [France] ; Nikolaos Scarmeas [États-Unis] ; Stephanie Cosentino [États-Unis] ; Elisabeth P. Helzner [États-Unis] ; Yaakov Stern [États-Unis] | Extrapyramidal Signs Before and After Diagnosis of Incident Alzheimer Disease in a Prospective Population Study |
| 000915 | A. Eusebio [France] ; J.-P. Azulay [France] ; T. Witjas [France] ; A. Rico [France] ; S. Attarian [France] | Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation |
| 000B61 | B. Dubois [France] ; A. Slachevsky [France, Chili] ; B. Pillon [France] ; R. Beato [France] ; J. M. Villalponda [France] ; I. Litvan [États-Unis] | "Applause sign" helps to discriminate PSP from FTD and PD |
| 000C27 | N. Scarmeas [États-Unis, Grèce] ; G. M. Hadjigeorgiou [Grèce] ; A. Papadimitriou [Grèce] ; B. Dubois [France] ; M. Sarazin [France] ; J. Brandt [États-Unis] ; M. Albert [États-Unis] ; K. Marder [États-Unis] ; K. Bell [États-Unis] ; L. S. Honig [États-Unis] ; D. Wegesin [États-Unis] ; Y. Stern [États-Unis] | Motor signs during the course of Alzheimer disease |
| 001B72 | P. Betermiez ; J. Delahousse ; J. L. Pedinielli | Les anti-cholinergiques au cours des traitements neuroleptiques. Intérêt et sevrage |
| This area was generated with Dilib version V0.6.29. |  |